Comments

BeOne Medicines Stock Price, Quotes and Forecasts

Q: What sector and industry does BeOne Medicines (ONC) operate in?

BeOne Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ONCNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

BeOne Medicines (ONC) Forecast

News Earnings BeOne Medicines (ONC) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

BeOne Medicines Stock Price, Quotes and Forecasts | NASDAQ:ONC | Benzinga

Explore BeOne Medicines stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ONC.

Open	$269.10
Close	-
Volume / Avg.	299.47K / 445.18K
Day Range	$268.69 - $272.82
52 Wk Range	141.31 - 287.88
Market Cap	$29.20B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	2.69%
Days to Cover	7.59

Recent News

CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

Chinese Biotech BeiGene Stock Falls Despite Strong Brukinsa Sales And Earnings Beat

BeiGene posted a surprise Q1 profit and $1.12 billion in revenue, with strong U.S. Brukinsa sales, while reaffirming its 2025 outlook and margin guidance.

Vandana Singh

Benzinga Bulls And Bears: Netflix, Novavax, Intel — And The Market Begins To Bounce Back

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.

Benzinga Senior Editor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$269.10
Close	-
Volume / Avg.	299.47K / 445.18K
Day Range	$268.69 - $272.82
52 Wk Range	141.31 - 287.88
Market Cap	$29.20B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	2.69%
Days to Cover	7.59

About BeOne Medicines Ltd

Sector

Health Care

Industry

Biotechnology

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commerc...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BeOne Medicines (ONC) stock?

You can purchase shares of BeOne Medicines (NASDAQ:ONC) through any online brokerage.

View our list of the best stock brokerages

Who are BeOne Medicines (ONC) competitors?

Other companies in BeOne Medicines’s space includes: Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).

What is the forecast, or price target, for BeOne Medicines (ONC) stock?

BeOne Medicines has a consensus price target of $326.43.

What is the current price for BeOne Medicines (ONC)?

The stock price for BeOne Medicines (NASDAQ: ONC) is $269.81 last updated June 13, 2025 at 2:55 PM EDT.

Does BeOne Medicines (ONC) pay a dividend?

There are no upcoming dividends for BeOne Medicines.

When is BeOne Medicines (NASDAQ:ONC) reporting earnings?

BeOne Medicines’s Q2 earnings are confirmed for Wednesday, August 6, 2025.

Is BeOne Medicines (ONC) going to split?

There is no upcoming split for BeOne Medicines.

What sector and industry does BeOne Medicines (ONC) operate in?

BeOne Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.